Apidra (insulin glulisine) is the newest rapid-acting insulin
March 2009
Apidra (insulin glulisine) is the newest rapid-acting insulin.
But it's just a "me-too"...similar to Humalog (insulin lispro) and NovoRapid (insulin aspart).
Patients will inject Apidra around meals...from 15 minutes before eating up to 20 minutes after starting a meal.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive